HeartBeam to prioritize heart attack detection, shares strategic focus
HeartBeam, Inc. has decided to prioritize heart attack (myocardial infarction) detection, redirecting the majority of its resources toward this opportunity. The company will continue limited commercialization of its existing arrhythmia product but will not build a large commercial organization around it. HeartBeam also